FGFR2-SORBS1 fusion
|
Cholangiocarcinoma
|
FGFR2-SORBS1 fusion
|
Cholangiocarcinoma
|
TAS 120 Resistant: C3 – Early Trials
|
TAS 120 Resistant: C3 – Early Trials
|
FGFR2-SORBS1 fusion
|
Cholangiocarcinoma
|
FGFR2-SORBS1 fusion
|
Cholangiocarcinoma
|
infigratinib Resistant: C4 – Case Studies
|
infigratinib Resistant: C4 – Case Studies
|